329 related articles for article (PubMed ID: 27438114)
1. Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy: US Nationwide Inpatient Database, 2003-2011.
Kim LK; Swaminathan RV; Looser P; Minutello RM; Wong SC; Bergman G; Naidu SS; Gade CL; Charitakis K; Singh HS; Feldman DN
JAMA Cardiol; 2016 Jun; 1(3):324-32. PubMed ID: 27438114
[TBL] [Abstract][Full Text] [Related]
2. Hospital Procedural Volume and Clinical Outcomes Following Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy.
Altibi AM; Ghanem F; Zhao Y; Elman M; Cigarroa J; Nazer B; Song HK; Masri A
J Am Heart Assoc; 2023 May; 12(10):e028693. PubMed ID: 37183831
[TBL] [Abstract][Full Text] [Related]
3. Differences in Short-Term Outcomes and Hospital-Based Resource Utilization Between Septal Reduction Strategies for Hypertrophic Obstructive Cardiomyopathy.
Yandrapalli S; Harikrishnan P; Andries G; Aronow WS; Panza JA; Naidu SS
J Invasive Cardiol; 2022 Jan; 34(1):E8-E13. PubMed ID: 34919530
[TBL] [Abstract][Full Text] [Related]
4. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
Poon SS; Field M; Gupta D; Cameron D
Interact Cardiovasc Thorac Surg; 2017 Jun; 24(6):951-961. PubMed ID: 28329292
[TBL] [Abstract][Full Text] [Related]
5. Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes.
Kimmelstiel C; Zisa DC; Kuttab JS; Wells S; Udelson JE; Wessler BS; Rastegar H; Kapur NK; Weintraub AR; Maron BJ; Maron MS; Rowin EJ
Circ Cardiovasc Interv; 2019 Jul; 12(7):e007673. PubMed ID: 31296080
[TBL] [Abstract][Full Text] [Related]
6. In-hospital outcomes of septal myectomy vs. alcohol septal ablation for hypertrophic cardiomyopathy with outflow tract obstruction: An update and insights from the national inpatient sample from 2011 to 2019.
Inestroza K; Mijares-Rojas I; Matute-Martínez C; Ergui I; Albosta M; Vergara-Sanchez C; Dangl M; Hernandez RJ; Ebner B; Vincent LT; Maning J; Alfonso C; Colombo R
J Investig Med; 2024 Mar; 72(3):262-269. PubMed ID: 38185664
[TBL] [Abstract][Full Text] [Related]
7. Septal Myectomy or Alcohol Ablation for Hypertrophic Cardiomyopathy: A Nationwide Inpatient Sample (NIS) Database Analysis.
Ullah W; Warner E; Khandait H; Sachdeva S; Abdalla AS; Shafique M; Khan MA; Roomi S; Khattak F; Alraies MC
Cardiovasc Revasc Med; 2023 May; 50():54-58. PubMed ID: 36737383
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Outcomes of Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Cardiomyopathy in Patients ≤65 Years Versus >65 Years.
Lemor A; Villablanca PA; Hosseini Dehkordi SH; Mand R; Hernandez GA; Jain T; Blumer VL; Lee J; Eng M; Guerrero M; Wang DD; Palacios I; O'Neill W
Am J Cardiol; 2020 Jul; 127():128-134. PubMed ID: 32402483
[TBL] [Abstract][Full Text] [Related]
9. Gender-Based Outcome Discrepancies in Patients Who Underwent Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis.
Saravanabavanandan R; Jaimalani A; Khan MAN; Riaz S; Mangas GM; Ahsan SM; Posani S; Patel T; Fawad M; Al-Tawil M
Am J Cardiol; 2023 Dec; 208():134-142. PubMed ID: 37839170
[TBL] [Abstract][Full Text] [Related]
10. A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy.
Liebregts M; Vriesendorp PA; Mahmoodi BK; Schinkel AF; Michels M; ten Berg JM
JACC Heart Fail; 2015 Nov; 3(11):896-905. PubMed ID: 26454847
[TBL] [Abstract][Full Text] [Related]
11. Impact of Septal Myectomy Volume on Mitral-Valve Replacement Rate in Hypertrophic Cardiomyopathy Patients.
Polanco AR; D'Angelo A; Shea N; Yu SN; Chiang YP; Shimada Y; Weiner SD; Takayama H
Cardiology; 2020; 145(3):161-167. PubMed ID: 32007988
[TBL] [Abstract][Full Text] [Related]
12. Survival After Septal Reduction in Patients >65 Years Old With Obstructive Hypertrophic Cardiomyopathy.
Mentias A; Smedira NG; Krishnaswamy A; Reed GW; Ospina S; Thamilarasan M; Popovic ZB; Xu B; Kapadia SR; Desai MY
J Am Coll Cardiol; 2023 Jan; 81(2):105-115. PubMed ID: 36631204
[TBL] [Abstract][Full Text] [Related]
13. Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience.
Steggerda RC; Damman K; Balt JC; Liebregts M; ten Berg JM; van den Berg MP
JACC Cardiovasc Interv; 2014 Nov; 7(11):1227-34. PubMed ID: 25326737
[TBL] [Abstract][Full Text] [Related]
14. Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.
Veselka J; Faber L; Jensen MK; Cooper R; Januska J; Krejci J; Bartel T; Dabrowski M; Hansen PR; Almaas VM; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg J; Liebregts M
Can J Cardiol; 2018 Jan; 34(1):16-22. PubMed ID: 29275877
[TBL] [Abstract][Full Text] [Related]
15. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in the Young and the Elderly.
Liebregts M; Steggerda RC; Vriesendorp PA; van Velzen H; Schinkel AF; Willems R; van Cleemput J; van den Berg MP; Michels M; ten Berg JM
JACC Cardiovasc Interv; 2016 Mar; 9(5):463-9. PubMed ID: 26965935
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Cost of Septal Myectomy Versus Alcohol Septal Ablation for Hypertrophic Cardiomyopathy.
Sun D; Schaff HV; Van Houten HK; Nguyen A; Sangaralingham LR; Nishimura RA; Geske JB; Dearani JA; Ommen SR
Mayo Clin Proc; 2022 Sep; 97(9):1656-1663. PubMed ID: 36058579
[TBL] [Abstract][Full Text] [Related]
18. A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy.
Singh K; Qutub M; Carson K; Hibbert B; Glover C
Catheter Cardiovasc Interv; 2016 Jul; 88(1):107-15. PubMed ID: 26526299
[TBL] [Abstract][Full Text] [Related]
19. Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta-analysis.
Osman M; Kheiri B; Osman K; Barbarawi M; Alhamoud H; Alqahtani F; Alkhouli M
Clin Cardiol; 2019 Jan; 42(1):190-197. PubMed ID: 30421437
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
Sedehi D; Finocchiaro G; Tibayan Y; Chi J; Pavlovic A; Kim YM; Tibayan FA; Reitz BA; Robbins RC; Woo J; Ha R; Lee DP; Ashley EA
J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
